Determination of idarubicin and idarubicinol in rat plasma using reversed-phase high-performance liquid chromatography and fluorescence detection

Journal of Chromatography B: Biomedical Sciences and Applications

Volumn 728, Issue 2, 1999, Pages 279-282

  Kuhlmann, Olaf ^a   Hofmann, Stefan ^b   Weiss, Michael ^a  

^a Section of Pharmacokinetics   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Idarubicin; Idarubicinol

Indexed keywords

IDARUBICIN; IDARUBICINOL;

ANIMAL EXPERIMENT; ARTICLE; CALIBRATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; FLUORESCENCE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PLASMA; PRIORITY JOURNAL; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DAUNORUBICIN; IDARUBICIN; MALE; RATS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, FLUORESCENCE;

EID: 0033066813     PISSN: 13872273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(99)00107-3     Document Type: Article

References (10)

1. Hollingshead L.M., Faulds D. Drugs. 42:1991;690-719.
2. Moro E., Bellotti V., Jannuzzo M.G., Stegnjaich S., Valzelli G. J. Chromatogr. 274:1983;281-287.
3. Oosterbaan M.J.M., Dirks R.J.M., Vree T.B., van der Kleijn E. J. Chromatogr. 306:1984;323-332.
4. Cummings J. J. Chromatogr. 341:1985;401-409.
5. Cummings J., Milroy R., Banham S.W., Kaye S.B. Cancer Chemother. Pharmacol. 19:1987;296-300.
6. Camaggi C.M., Carisi P., Strocchi E., Pannuti F. Cancer Chemother. Pharmacol. 30:1992;303-306.
7. Eksborg S., Nilsson B. J. Chromatogr. 488:1989;427-434.
8. Looby M., Linke R., Weiss M. Cancer Chemother. Pharmacol. 39:1997;554-556.
9. C. Sachse. Diplomarbeit, Martin-Luther-Universität Halle-Wittenberg, Fachbereich Biochemie/Biotechnologie (1994).
10. M. Weiss, O. Kuhlmann, S. Hofmann. In preparation.